2cureX AB
2CUREX | ST
Overview
Corporate Details
- ISIN(s):
- SE0010468124
- LEI:
- 549300SFOL75WIYF2O80
- Country:
- Sweden
- Address:
- Box 159, 261 22 Landskrona
- Website:
- https://www.2curex.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
2cureX AB is a biotechnology company specializing in functional precision oncology. The company develops and commercializes the IndiTreat® family of tests, a CE IVD-marked platform for cancer drug sensitivity testing. IndiTreat® utilizes patient-derived 3D tumoroids, which are micro-tumors grown from a patient's biopsy, to test the efficacy of various cancer treatments. By providing data on how a specific tumor responds to different drugs, the platform empowers oncologists to make more informed, personalized treatment decisions for cancer patients, with an initial focus on metastatic colorectal cancer.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for 2cureX AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all 2cureX AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for 2cureX AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
